← Back to headlines
Pfizer Announces FDA Approval for PADCEV plus Keytruda in MIBC
Pfizer (PFE) has announced that the FDA has approved PADCEV in combination with Keytruda for the treatment of MIBC (muscle-invasive bladder cancer).
15 Jul, 14:24 — 15 Jul, 14:24
Sources
Showing 1 of 1 sources
